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Abstract 
    Age-related macular degeneration is a debilitating condition that manifests as a loss of the 
central portion of an individual’s field of vision, affecting 1 in 3 people over the age of 80. With 
regards to the retina, the organ primarily responsible for an individual’s sense of vision, this 
condition is associated with the degeneration of the central point in the retina, known as the 
macula, which contains the highest concentration of light-sensitive photoreceptors. It is 
currently known that the human retina exhibits a gradual decrease in protective detoxifying 
factors such as glutathione-S-transferase-1 and catalase as well as increased lipid peroxidation, 
all of which resulting in the age-related increase in autofluorescent lipofuscin between the 
retina and the choroid. This prevents the proper deliverance of nutrients to the foundational 
layer of cells in the retina, leading to oxidative stress-related apoptosis of first the retinal 
pigmented epithelium (RPE) and then the photoreceptors. 
    MicroRNAs (miRNAs) are a group of endogenous noncoding RNA molecules that originate 
from parts of the genome that were originally speculated to be “junk” DNA. However, it is now 
known that these small RNA molecules are responsible for gene silencing on the post-
transcriptional level via the degradation or transcription inhibition of specific mRNA transcripts. 
In the context of age-related macular degeneration, certain miRNAs may be upregulated to 
induce the downregulation of apoptotic genes. On the other hand, certain miRNAs is may 
become downregulated to promote enhanced expression of protective factors. We hypothesize 
that miRNAs play a role in regulating oxidative response of RPE cells, which may then 
contribute to cell survival by the upregulation of endogenous pro-survival antioxidant elements. 
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Introduction 
Anatomy of the Retina 
    The vertebrate retina is a multilayered structure composed of multiple cell types, including 
rod and cone photoreceptors, ganglion and amacrine cells, and retinal pigmented epithelium 
cells (RPEs). These cells are arranged in layers at the back of the eye, forming a complex neural 
network that allows for the sense of sight.[1] As shown in Figure 1, this multilayered structure 
lines the back of the eye between a vascular layer, known as the choroid, and the vitreous gel. 
The retina itself is known to be made up of two distinct regions. The neuroretina is composed 
of various neural cell types such as the rod and cone photoreceptors, amacrine cells and 
ganglion cells, all of which are collectively responsible for relaying signals generated by light 
coming into the eye. In this process, light enters the eye through the lens and excites the light-
sensitive photoreceptors. These cells then send signals via the amacrine cells to the retinal 
ganglion cells, whose axons form the optic nerve by which these signals are sent to the brain. 
    The second region of the retina is known as the pigmented epithelium, which is a layer of 
cells known as retinal pigmented epithelial cells (RPEs). This layer of cells plays multiple 
important roles in maintaining the intercellular homeostasis of the neuroretina, including the 
phagocytosis of outer segments shed by the photoreceptors,[2] maintaining the separation 
between the neuroretina and the blood supply by the formation of tight junctions,[3] the 
transfer of ions and other nutrients from the blood supply to the neuroretina,[4] and the 
conversion and storage of retinoid as part of the visual transduction cycle.[5] 
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Figure 1: Anatomy and Functional Schematic of the Vertebrate Retina. Modified from “How the Retina Works,” 
American Scientist, (91) 2003. a. Anatomical diagram of the eye with emphasis on the retina and the cellular layers 
it is composed of. b. Functional schematic of the retina.  
    Visual impairment can result from damage to the retina from various sources that one may 
encounter during his or her lifespan. Age-related macular degeneration (AMD) is an example of 
the lifelong progression in which the accumulation of damage to the retina can coalesce in the 
loss of sight, which can be a problematic issue with regards to the quality of life in the aging 
population. There are two types of cells currently under investigation in the context of age-
related retinal degeneration: the light sensitive rod and cone photoreceptors found in the 
neuroretina and the RPE cells that form the foundation of the retina. Functionally, as previously 
mentioned, the RPE cells provide structural and nutrient support for the photoreceptors. 
Therefore, the pigmented epithelium plays a vital role in the viability of the retina, the 
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degeneration of which would inevitably lead to the degeneration of downstream cells such as 
the photoreceptors.[6]  
Age-Related Macular Degeneration: Symptoms and Treatments 
    Age-related macular degeneration (AMD) is a prime example of a neurodegenerative 
phenomenon, displaying an age-related progression of degeneration in the retina. AMD is the 
leading cause of vision loss in people over the age of 50 years, affecting approximately 15 
million people in the U.S. The condition is characterized by the deterioration of the macula, a 
portion of the retina that contains the largest concentration of cone photoreceptor cells and is 
responsible for high resolution vision. There are two main forms of AMD: dry and wet. Wet 
AMD, the more rare form of AMD, is associated with the resulting retinal detachment due to 
the formation of new blood vessels in the retina. Dry AMD, which accounts for over 90% of 
AMD cases, is associated with the age-related build-up of cellular debris between Brusch’s 
membrane and the RPE layer. This accumulation continues with age, leading to the atrophy and 
eventual death of the pigmented epithelium, ultimately disrupting the cellular homeostasis of 
downstream retinal cells and eventually cell death of cells in the neuroretina.[7] This 
progression is outlined in Figure 2.  
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Figure 2: Progression of Cell Death Exhibited in AMD. As cellular debris builds up between Brusch’s membrane 
and the RPE layer, cells in the RPE layer eventually undergo cell death. As more RPE cells die due to cellular stress, 
intercellular homeostasis in the neuroretina is disrupted, leading to the cell death of photoreceptors and other 
neural cells.  
    Symptoms of AMD include the perceived distortion of straight lines, diminished or changed 
color perception, and dark blurry areas or white-outs that appear at the center of vision. As a 
result, individuals affected by AMD will present with “reversed tunnel-vision,” where they have 
a blind spot at the center of their field of vision that grows outward with age, as described in 
the simulation from the National Eye Institute in Figure 3. Eventually the blind spot will 
gradually progress outward with age as more retinal cells succumb to the degenerative process. 
In the more advanced form of this degeneration, affected individuals will develop the condition 
known as geographic atrophy (GA), at which point the deterioration completely disrupts the 
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layer of pigmented epithelial cells, leading to legal or complete blindness if a clinical 
intervention isn’t administered.  
 
Figure 3: Field of Vision Perceived by an Individual Affected by AMD Compared to an Unaffected Individual. 
Compared to an individual unaffected by AMD, an AMD patient experiences a blind spot at the center of their field 
of vision. With age, as retinal cell death accumulates due to increasing cellular stress, this blind spot grows 
outward. Eventually, without intervention, this phenomenon will result in legal or complete blindness. 
     
        To date, there are no treatments that have been shown to effectively halt the 
degeneration of the retina or rescue vision once cells in the retina have been lost. Therefore, 
current aims in scientific research are focused on the prevention of this degeneration. With 
regards to therapeutics, drugs used in the treatment of AMD are VEGF-inhibitors which attempt 
to halt retinal degeneration through the neovascularization process associated with wet 
AMD.[8] However, this has no use in the treatment of the dry form of AMD, which doesn’t 
manifest through the neovascularization process. Additionally, VEGF-inhibitor treatments have 
not been shown to completely rescue the vision of such an affected individual once retinal cells 
are lost to the degenerative process. Therefore, current strategies that are under scientific 
investigation include gene therapy and cell-replacement therapy. Although gene therapy has 
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been valued in the treatment of various conditions, the drawback in this case once again lies in 
its use in late stage AMD. The data presented by Maguire et al. in 2009 shows that the best 
visual improvements after the use of adeno-associated viruses to restore the functionality of 
RPE65, a marker of cellular maturity in RPEs, has been seen only in children, whose 
photoreceptors have not already been lost to the degeneration process.[9] Furthermore, gene 
therapy is generally most useful in conditions where a loss-of-function mutation is observed or 
enzyme replacement is necessary, both of which are not the case for AMD and thus have 
limited therapeutic use for the prevention of retinal degeneration.  
    Current research endeavors regarding the treatment of AMD highlight the use of embryonic 
stem cells and induced pluripotent stem cells to replace retinal cells that have been lost to the 
degenerative process. Various groups focus on the inhibition of Wnt and BMP signaling 
pathways along with the activation of IGF signaling  in order to derive retinal cells from 
pluripotent stem cells.[10-12] Additionally, differentiated retinal cells derived in such a manner 
have been shown to exhibit integration and survival after transplantation, even providing a 
rescue of sight in a Crx-deficient mouse model, albeit to a limited extent.[13-15] To date, non-
mammalian vertebrates have been shown to have the remarkable ability to  replace neurons 
that have been lost by damaging events.[16-18] However, this phenomenon has yet to be seen 
to any significant extent in humans. Therefore, despite advances in therapeutic treatments for 
AMD by cell-replacement strategies, mechanistic studies promise to be invaluable clinical assets 
in order to elucidate preventative strategies for the retinal degenerative process.  
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Oxidative Stress as a Key Factor in the Progession of AMD 
    In  light of the potential of understanding the mechanisms through which AMD progresses, 
many investigators focus on defining factors  that contribute to the degenerative nature of 
AMD. From such information, strategies can be developed to help slow or prevent the 
degenerative process. Current research speculates the beneficial effects of omega-3 fatty acids 
and various antioxidant molecules in measures to prevent AMD, implicating the role of diet.[19] 
In one such study, omega-3 fatty acids were shown to have beneficial effects on AMD-like 
legions in DKOrd8 mice by anti-inflammatory mechanisms of docosahexaenoic acid and 
eicosapentaenoic acid (EPA).[20] Other environmental factors that have been implicated in the 
development of AMD include smoking and exposure to smoke, which have been shown to 
cause systemic oxidative stress,[21, 22] as well as genome instability and DNA damaged caused 
by exposure to blue and ultraviolet (UV) light.[23] Genetic factors have also been proposed to 
play a role in the progression of AMD. It has been shown that mutation-induced dysfunctional 
expression of complement factor H is strongly associated with AMD development through the 
induction of chronic inflammation, leading to excessive cellular damage to retinal cells.[24, 25] 
    Because the underlying cause of AMD is complex and multifactorial, a single underlying factor 
that drives the degenerative process is considerably difficult to define. This problem is 
compounded due to the fact that most animal species lack a macula, therefore finding the 
appropriate animal model system for in vivo studies is quite difficult.[26] Recent studies have 
associated oxidative stress as a key element in the progression of AMD, presenting evidence of 
a decreased expression in glutathione S-transferase-1, increased lipid peroxidation, and a 
decreasing trend in catalase activity that continues with age.[27] As a result, there is an age-
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related increase in autofluorescent lipofuscin between the RPE layer and Brusch’s membrane. 
This substance contains a molecule known as A2E, a pyridinium bisretinoid byproduct of the 
visual phototransduction pathway. Importantly, A2E is known to be a potent generator of 
reactive oxygen species (ROS) in the RPE, the accumulation of which can lead to cell death.[28] 
Therefore, understanding how the RPE reacts, and what pro-survival mechanisms are affected 
in response to oxidative stress, has potential for further investigations into preventative 
measures against AMD. One way to investigate cellular response to stress is by focusing on the 
production of endogenous factors that can play a role in pro-survival mechanisms and how the 
expression of such factors are affected by cell stress.  
    One of the most notable signaling pathways that have been associated with oxidative stress 
response is the NRF2/KEAP1 pathway. This signaling pathway implements cellular responses to 
oxidative stress through the production of antioxidant response elements (AREs).[29, 30] Under 
basal conditions, KEAP1 is bound to NRF2, which then directs NRF2 into degradation in the 
cytosol. However, as visually outlined in Figure 4, the accumulation of ROS in the event of 
oxidative stress leads to the dissociation of KEAP1 from NRF2, stabilizing this factor. NRF2 is 
then translocated into the nucleus where it induces the expression of AREs such as NAD(P)H 
dehydrogenase quinone 1 (NQO1), heme oxygenase 1 (HMOX1), as well as the catalytic and 
regulatory subunits of glutamate-cysteine ligase (GCLC and GCLM respectively). 
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Figure 4: NRF2/KEAP1 Signaling Pathway.  
 
Basic Biology of miRNAs 
     Various studies highlight the role of small, noncoding RNA molecules known as microRNAs 
(miRNAs) in the progression of various human disease conditions.[31] These 22-25 nucleotide 
small RNA molecules silence gene expression via the degradation or translational inhibition of 
target mRNA molecules. Such molecules had escaped the notice of many researchers until 
1993, when Victor Ambros, Rosalind Lee, and Rhonda Feinbaum discovered that lin-4, a gene 
known to play a significant time-dependent role in C. elegans larval development, does not 
encode a protein. In fact, when expressed, the gene produces a pair of small RNA molecules 
that have been suggested by the group to inhibit lin-14 expression by RNA-RNA antisense 
interactions.[32]  
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Figure 5: miRNA Biogenesis Pathway. Complete processing of miRNA transcripts leads to the loading of the 
mature miRNA molecule onto the RNA-induced silencing complex, which targets specific messenger RNA 
sequences for gene silencing. 
 
    As outlined in Figure 5, the production of mature miRNAs follows a distinctly different 
pathway from that of functional messenger RNAs. miRNA genes are transcribed by RNA 
polymerase II to produce a primary miRNA (pri-miRNA) transcript, which is then processed by a 
microcompressor complex comprised of two factors, DROSHA1 and DGCR8, to produce the pre-
miRNA transcript. This product is exported out of the nucleus by Exportin 5 and then processed 
by DICER1 to form a miRNA duplex composed of 5p and a 3p strands. This duplex dissociates 
and the mature 5p component is loaded onto the RNA-Induced silencing complex to form the 
miRNA-RISC, which then binds to the 3’ untranslated region (3’UTR) of specific mRNA 
transcripts. 
11 
 
    With regards to function, an individual miRNA molecule is as important to gene expression as 
an individual transcription factor, in this case to regulate the expression of multiple target 
genes at the post-transcriptional level.[33] After a mature miRNA transcript is loaded onto the 
RISC, the miRNA-RISC can target specific messenger RNA (mRNA) transcripts for gene silencing 
depending on the extent of complementary binding. Complete complementarity effectively 
leads to the degradation of the mRNA molecule by the RISC. Partial complementarity between 
an miRNA-RISC and an mRNA transcript doesn’t degrade the mRNA molecule, however it does 
prevent its translation into a functional protein. Therefore, any binding of an miRNA-RISC to an 
mRNA molecule effectively leads to gene silencing at the post-transcriptional level. It is 
speculated that miRNAs may be involved in the regulation of all major cellular functions in the 
cell, including differentiation, replication, mobility, and apoptosis through the inhibition of key 
mRNA gene targets. Therefore, such molecules present much potential in the study of 
development, physiology, and disease in humans. 
 
MicroRNAs in RPE Cells 
    With regards to the context of retinal cells, past studies highlight the expression and 
inhibition of miRNAs such as miR204, miR302,[34] miR184, miR187, and miR211[35] in the 
maintenance of RPEs. For example, it has been reported that the continuous expression of 
miR204 and the continuous inhibition of miR302 contributes to the expression of markers such 
as ZO-1, RPE65, MERTK, and MiTF through the specific targeting of CTNNBIP1, a reported 
inhibitor of Wnt signaling, and TGFBR2, a factor that aids in the direction of the mesodermal 
and endodermal cell fates, respectively.[34]  Of particular note, it has been shown that miRNAs 
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play a role in RPE cell viability in the pathogenesis of AMD through the dysregulation of 
protective miRNAs[31] or the accumulation of ALU RNA elements. In both instances, the 
disease progression has been suggested to be driven by the loss of DICER1, a key protein 
involved in miRNA biogenesis.[36] Additionally, recent studies have observed shifts in miRNA 
expression profiles when comparing human ARPE-19 cells that have undergone H2O2-induced 
oxidative stress or treatment with the antioxidant curcumin.[37] Although this study involved 
only acute treatments of H2O2 rather than chronic treatments, which would be a more 
appropriate experimental design to study AMD with, this indeed suggests the presence of 
miRNA-dependent pro-apoptotic and anti-apoptotic mechanisms in RPE cells that are activated 
in response to stress signaling.  
 
Research Focus 
    As described previously, miRNAs are thought to play a role in how cells react to stress and 
disease conditions. Data from immortalized cell lines such as ARPE-19 may not accurately and 
comprehensively represent the disease due to the highly proliferative nature of the cell line’s 
biology. Therefore, RPEs derived from human embryonic stem cells (hESCs) appear to be the 
ideal candidate for studies on the miRNA profiles of the AMD disease phenotype. Although 
there have been investigations into miRNA and gene profiling of short-term stress phenotypes, 
there has yet to be a comprehensive study looking into such profiling associated with long-term 
stress with a gradually increasing concentration of stressor, which would be a more appropriate 
model of AMD. This would be more adequately reflective of the accumulation of lipofuscin 
products under the RPE layer. Based on previously published methods of deriving retinal cell 
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types from hESCs, including the RPE cell fate[11] our lab seeked to develop a model system 
displaying the chronically stressed phenotype associated with AMD through paraquat-induced 
chronic oxidative stress.[38] Once a model system has been developed, changes in miRNA 
expression can then be monitored by quantitative PCR analysis with modifications designed for 
the analysis of mature miRNA molecules.[39] This information can then be cross-referenced to 
the expression profile of protective antioxidant factors such as those found in the NRF2/KEAP1 
pathway. 
 
Materials and Methods 
Cell Culture and RPE Determination Conditions 
    Undifferentiated embryonic stem cells or induced pluripotent stem cells derived from a 
patient with Leber’s congenital amaurosis were maintained in Essential 8 basal medium (Gibco) 
supplemented with 1% Essential 8 supplement (Gibco) and 1% Pen/Strep Amphotericin B 
(Lonza) on culture vessels coated with Matrigel (BD Biosciences). The media of these cells were 
changed every day and grown in a 37o C incubator with 5% CO2 and 5% O2 before 
differentiation. Differentiated RPE cells were maintained in MEM/EBSS with 2.00 mM L-
Glutamine and Earle’s balanced salts (Hyclone) supplemented with Knockouttm serum 
replacement (Gibco), 1% for maintenance of mature RPEs and 5% for the proliferation of RPEs 
to confluency before maturation, 1% Pen/Strep Amphotericin B (Lonza), 1% Glutamaxtm 
(Gibco), 125 mg taurine, 10 µg hydrocortisone, 6.5 ng triiodo-thyronin, and 0.1% plasmocin 
prophylactic (InvivoGen). The media of RPE cells was changed every other day, grown and 
maintained in a 37o C incubator with 5% CO2. 
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    For the differentiation of embryonic stem cells into the RPE fate, undifferentiated cells were 
subjected to a 3 week of treatment with 10 ng/mL DKK1 (R&D Systems), noggin (R&D Systems), 
and IGF1 (R&D Systems) in DMEM/F-12 1:1 with 2.50 mM L-Glutamine and 15 mM HEPES 
(HyClone), 1% sodium pyruvate (Corning), 1% N-2 supplement (Gibco), 1% HEPES (HyClone), 1% 
Pen/Strep Amphotericin B (Lonza), and 0.1% plasmocin prophylactic (InvivoGen). 
Spontaneously appearing pigmented foci were picked and transferred to a separate culture 
vessel coated with Matrigel for expansion and complete formation of traditional cobblestone-
like morphology. 
 
Stress Treatment of RPEs 
    Once hESC-derived RPEs have grown to 100% confluency, cells were subjected to treatment 
with either paraquat (PQ), alternatively known as methyl viologen (Acros Organics), and 
hydroquinone (Acros Organics) in order to induce either a low stress or chronic high stress 
phenotype. To induce a low stress phenotype, RPE cells were treated with either stressor. The 
cells were treated with either 20 µM of paraquat or 50 µM of hydroquinone over 9 days and 
followed by 40 µM of paraquat or 100 µM of hydroquinone subsequently over 7-10 days.  
    To induce a high stress phenotype, RPE cells were treated in a similar manner. Paraquat 
treatment involved 40 µM of paraquat over 9 days then 80 µM over the following 6 days, and 
finally 160 µM over 5 days. In a similar fashion, hydroquinone treatment involved 100 µM over 
9 days, 200 µM over the next 7 days, and 400 µM over 1 day. After each series of treatments, 
RNA was extracted for miRNA analysis by real-time quantitative PCR. 
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RNA Extraction, Reverse Transcription, and PCR Analysis 
    Total RNA was extracted from RPE cells using the Direct-zol RNA MiniPrep kit (Zymo 
Research) according to the manufacturer’s recommended instructions. RNA samples were then 
quantified by a NanoDrop 2000 apparatus (Thermo Scientific). cDNA was synthesized from 0.5-
1 µg of total RNA template using the iScript cDNA Synthesis kit (Bio-Rad), the protocol of which 
was modified to accommodate 400 nM of a reverse transcription stem-loop primer. Up to 5 
reverse transcription stem-loop primers were used per reaction. Reactions occurred in a T100 
Thermal Cycler (Bio-Rad) according to the manufacturer’s recommended instructions with the 
addition of stem-loop oligonucleotide primers for mature miRNA transcripts.  
   Real-Time Quantitative PCR analysis was performed using a Bio-Rad CFX Connect Real-Time 
PCR Detection System. Acquisition of data was then performed on a Bio-Rad CFX Manaer 
software. Each 20 uL reaction was done in triplicate, each replicate comprising of a miRNA-
specific forward primer, which binds to a miRNA of interest, and a universal reverse primer that 
binds to the stem-loop structure created by the reverse transcription stem-loop primer. Both 
primers were used at a final concentration of 400 nM with 1 µL cDNA diluted five-fold, 7.4 µL of 
DEPC-treated water, and 10 µL of iTaq Universal SYBR Green Supermix (Bio-Rad).  Sample data 
values from quantitative PCR analysis were normalized to U6 small nuclear RNA-2 (RNU6-2). 
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Target 
miRNA 
Mature Sequence Forward Primer Reverse Transcription Stem-loop Primer  
200a CAUCUUACCGGACAGU 
 
GCGGCCATCTTACCGGACA GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGTGCTGGA 
27b AGAGCUUAGCUGAUUG
GUGAAC 
 
GGCGCAGAGCTTAGCTGAT 
 
GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATGGTGAAC 
 
21 UAGCUUAUCAGACUGA
UGUUGA 
GGCGCGTAGCTTATCAGACT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGATGTTGA 
 
29b1 GCUGGUUUCAUAUGGU
GGUUUAGA 
GGCGGCTGGTTTCATATGG GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGGTTTAGA 
 
29a UAGCACCAUCUGAAAUC
GGUUA 
GCGGGTAGCACCATCTGAA GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAATCGGTTA 
 
302c UAAGUGCUUCCAUGUU
UCAGUGG 
GGCGCTAAGTGCTTCCATGT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATTCAGTGG 
 
126 CAUUAUUACUUUUGGU
ACGCG 
GGCCGGCGCATTATTACTTT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAggtacgcg 
GGTACGCG 
 
146a UGAGAACUGAAUUCCA
UGGGUU 
GGCGCGTGAGAACTGAATTC GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGACATGGGTT 
 
144 GGAUAUCAUCAUAUAC
UGUAAG 
GCGGGCGGATATCATCATAT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAACTGTAAG 
 
23a GGGGUUCCUGGGGAUG
GGAUUU 
GCGGGGGTTCCTGGGGA GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATGGGATTT 
 
149 UCUGGCUCCGUGUCUU
CACUCCC 
GGCTCTGGCTCCGTGTCT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATCACTCCC 
 
27a AGGGCUUAGCUGCUUG
UGAGCA 
GGCGAGGGCTTAGCTGCT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATGTGAGCA 
 
20a UAAAGUGCUUAUAGUG
CAGGUAG 
GGCCGCTAAAGTGCTTATAG GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGCAGGTAG 
 
92a AGGUUGGGAUCGGUUG
CAAUGCU 
GGCGAGGTTGGGATCGGTT GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGCAATGCT 
 
 
Primer Sequence 
Universal Reverse Primer GCGCTACTTACTGGACACTG 
 
 
Table 1: List of Primers Used for qPCR Analysis of mature miRNA transcripts. 
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Gene Target Forward Primer Reverse Primer 
RNU6-2 TGGAACGATACAGAGAAGATTAG 
 
TGGAACGCTTCACGAATT 
GCLC AAGTGGATGTGGACACCAG CTGTCATTAGTTCTCCAGATGC 
GCLM GTTGACATGGCCTGTTCAG AACTCCATCTTCAATAGGAGGT 
HMOX1 AACTCCCTGGAGATGACTC CTCAAAGAGCTGGATGTTGAG 
NQO1 ACATCACAGGTAAACTGAAGG ACATCACAGGTAAACTGAAGG 
P21 GACACCACTGGAGGGTGACT CAGGTCCACATGGTCTTCCT 
 
Table 2: List of Primers Used for qPCR Analysis of Gene Targets.  
 
Dichlorofluorescein Assay for ROS generation 
    To screen for ROS generation at a given time, 2’,7’-dichlorofluorescein 3’,6’-diacetate (Acros 
Organics) diluted in DMSO to make a 10 mM stock solution was diluted to 5 µM with 1x Hank’s 
Balanced Salt Solution (Cellgro). RPE cells were then incubated in this solution for 30 minutes 
before images were taken under fluorescent microscopy. 
 
Lentiviral Transduction of RPE cells for Manipulation of miRNA Expression 
    miRNA decoy expression plasmids used in this study were purchased from the Addgene 
plasmid depository, including miR27b decoy (Addgene plasmid# 46603) and miR29b decoy 
(Addgene plasmid# 46605)[40] expression plasmids. The miRNA expression plasmid used for 
the overexpression of miR144-5p was purchased from Genecopoeia (HmiR0275-MR03). Data 
obtained from the use of this plasmid was referenced to the use of a non-silencing, scrambled 
miRNA expression plasmid that was also purchased from Genecopoeia (CmiR0001-MR03-B). 
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     HEK293T cells were plated in 10-cm dishes and allowed to grow to ~70% confluency.  4 µg of 
miR decoy expression plasmid was incubated with 2 µg pMD2 VSVG and 2µg of psPAX2 
lentiviral packaging plasmids in 750 µL of Cellgro Complete serum-free/low protein medium, 1X 
(Corning). 45 µL of TransIT-LT1 (Mirus Bio) also incubated with 750 µL of Celgro Complete 
medium. The two components incubated for 5 minutes at room temperature and then 
incubated together for 15 minutes. The mixture was then added directly onto the cells. The 
cells incubated at 37o C with 5% CO2 for 16 hours at which point, the lentivirus-containing 
media was collected and replaced with Cellgro Complete medium with 1% FBS. Lentivirus-
containing media was then collected every 12 hours for up to 48 hours post-transfection.  
Before transduction of RPE cells, lentivirus-media was filtered through a 0.45µm vacuum-driven 
filter.  
    Once filtered, virus-containing media supplemented with polybrene (at a final concentration 
of 4 µg/mL) was incubated with RPE cells over the course of 2 weeks, with media changes after 
every 2 days.  
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Results and Discussion 
Establishment of Oxidative Stress Phenotype Reflective of AMD 
 
Figure 6: Establishment of the AMD phenotype by the induction of oxidative stress in hESC-derived RPE cells a. 
Undifferentiated hESC colonies in feeder-free condition. b. hESC-derived RPE cells displaying typical cobblestone-
like morphology without stressor treatment. c. hESC-derived RPE cells subjected to 1 week of treatment with 
hydroquinone. d. hESC-derived RPE cells subjected to an additional week of oxidant treatment, with 200 uM of 
hydroquinone. e. hESC-derived RPE cells subjected to 1 week of treatment with paraquat. f. hESC-derived RPE cells 
subjected to an additional week of paraquat treatment at a 160 uM concentration.  
 
    We began this study by the derivation of RPE cells from undifferentiated embryonic stem 
cells or iPSCs derived from patients affected with Leber’s congenital amaurosis, as seen in 
Figure 6a. These cells were then subjected to treatment with DKK1, noggin, and IGF according 
to published protocols[11]. After 2-3 weeks of treatment with these factors, clusters of cells 
exhibiting a cobblestone-like epithelial morphology were manually extracted and transferred 
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into separate culture vessels for proliferation and maturation, resulting in a monolayer of 
pigmented cells with a uniform morphology, as seen in Figure 6b. 
    We then conducted experiments to identify sublethal concentrations of hydroquinone and 
paraquat for the treatment of hESC-RPEs, which would allow us to induce an oxidatively 
stressed state with RPE cells without the activation of cellular pathways associated with 
programmed cell death. This will allow us to identify pro-survival molecular pathways involved 
in the cellular response to stress by PCR under high and low oxidative stress conditions. As 
noted previously, we also aimed to develop a protocol of oxidative stress induction based on 
the idea of a gradually accumulating stressor.  
   With the use of hydroquinone to induce a low stress phenotype, we found that the RPE cells 
were able to stay alive at 50 µM of hydroquinone for 9 days, seen in Figure 6c at the 1-week 
time point, and then 100 µM over the next 7 days. In order to induce a high, chronic stress 
phenotype, we found we were able to use 100 µM of hydroquinone over 9 days, 200 µM over 
the next 7 days, and then 400 µM over the following day.  
     In terms of the using paraquat to induce a low stress phenotype, we found that RPE cells 
were able to stay alive at  20 µM paraquat over 9 days, which is seen in Figure 6e at the 1-week 
time point, and then at 40 µM over the following 10 days.  To induce a high, chronic stress 
phenotype with paraquat, we were able to use 40 µM of paraquat over 9 days, 80 µM over the 
next 6 days, and then 160 µM over the following 5 days. Upon further increase in concentration 
of either hydroquinone or paraquat or time of stressor treatment, RPE cells have often been 
seen to undergo apoptosis.  
21 
 
    With the use of both paraquat and hydroquinone, we were able to observe a change in the 
traditional cobblestone-like morphology of RPE cells. Although this is less pronounced in the 
use of paraquat, we have noted that these cells take on a more elongated morphology 
reminiscent of fibroblasts, which we believe indicates an extent of an epithelial-to-
mesenchymal transition which is reflective of the proliferative characteristics of RPE cells. We 
were able to then validate the generation of ROS associated with the incubation with oxidant 
stressor by DCF staining of intracellular ROS, as seen in Figure 7. 
 
 
 
Figure 7: Assessment of ROS Generation Associated with the use of Paraquat by DCF Assay. a. Untreated hESC-
RPE cells incubated with DCF, resulting in little to no fluorescence. b. hESC-RPE cells treated with paraquat at 160 
µM (PQ160) after increasing concentrations of stressor, resulting in higher fluorescence intensity as seen in the 
quantification in c. by Image J software. 
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Correlation of Oxidative Stress Phenotype with NRF2/KEAP1 Activity and miRNA Analysis 
 
Figure 8: Gene Analysis of Products of NRF2/KEAP1 Pathway Generated by Stress Signaling Gene expression 
analysis of RPE cells subjected to chronic oxidative stress by hydroquinone up to a. 400 µM of hydroquinone 
(HQ400) and b. 160 µM paraquat (PQ160). c. Unaffected RPEs compared to d. RPEs after 1 week treatment of 160 
µM paraquat, both stained for NRF2. 
 
    Once an observable phenotype was seen in cells treated with oxidative stressors, we sought a 
means to measure this phenotype through the analysis of pro-survival mechanisms. We elected 
to check for the activity of the NRF2/KEAP1 pathway, a pathway known to play a significant role 
in the production of endogenous antioxidant response elements (AREs) in lieu of stress 
signaling. As seen in Figure 8a and 8b, both paraquat and hydroquinone were able to induce the 
production of downstream products of the NRF2/KEAP1 pathway, including GCLC, GCLM, 
HMOX1, and NQO1 by at least a 4-fold increase compared to untreated RPE control cells. 
Interestingly, we also found that P21, a factor associated with cell cycle arrest and anti-
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proliferative conditions[41] is also upregulated with stressor treatment. Additionally, p21 has 
been shown to stabilize NRF2 by competitive binding, preventing KEAP1 from binding to NRF2. 
This ultimately prevents the KEAP1-induced ubiquitination of NRF2 and therefore promotes a 
pro-survival oxidative stress response.[42] We have also been able to confirm the translocation 
of NRF2 into the nucleus and therefore the induction of endogenous antioxidant element 
expression by immunostaining, as seen Figure 8c and 8d. 
    Next, we looked for potential miRNA candidates that may exhibit significant change in 
expression due to oxidative stress signaling. Through various publications, we found a number 
of potential miRNA candidates that may play a role in oxidative stress signaling as well as cancer 
pathology. This list of miRNAs include miR200a[43], miR27b[44], miR23b[45], miR146a[46], 
miR29a[47], miR29b[48], miR143[49], miR144[50]. As seen in Figure 9a and 9b, various miRNAs 
such as miR27b, miR29b1, miR302c, miR126, and miR146a are upregulated by at least a 4-fold 
difference with a lower concentration of paraquat, and miR200a, miR27b, miR23a, miR144, 
miR149, and miR27a are upregulated by a similar amount. Both profiles suggest a negative 
regulatory effect on gene mRNA transcripts, which may in fact play a role in the survival of RPEs 
in light of an oxidant stressor. As seen in Figure 9c and 9d, various miRNAs such as miR20a, 
miR29b1, miR29a, miR302c, and miR146a are upregulated under chronic oxidative stress 
conditions with a higher concentration of hydroquinone. Interestingly, there are increases in 
the expression of miR146a and miR29a under chronic oxidative stress conditions with a higher 
concentration of paraquat, along with a rather striking decrease in miR144. This suggests a 
dramatic upregulation in the gene targets associated with miR144-target UTR binding.  
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Figure 9: Changes in miRNA expression profile associated with the oxidative stress phenotype a. and b. miRNA 
expression profile of RPE cells subjected to low experimental oxidative stress with paraquat and hydroquinone. 
miRNA analysis was performed on RPEs treated with up to 40 µM of paraquat (PQ40) and 100 µM of hydroquinone 
(HQ100) with increasing concentrations of stressor as previously noted. c. and d. miRNA expression profile of RPE 
cells subjected to experimental chronic oxidative stress  with paraquat and hydroquinone. miRNA analysis was 
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performed on RPEs treated with up to 400 µM of hydroquinone (HQ400) and 160 µM of paraquat (PQ160) with 
increasing concentrations of stressor as previously noted. 
 
Low Stress High Stress Both 
Up: miR126, miR149, miR23a, miR126 Down: miR144  
Up: miR20a 
Up: miR29b1, miR29a, miR302c, 
miR146a, miR27b,  
miR144, miR27b up in low stress, down 
in high stress 
 
Table 3: Changes in miRNA Expression Associated with High and/or Low Oxidative Stress conditions 
 
Modulation of miRNAs Associated with Oxidative Stress and its Effect on Stress Phenotype 
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Figure 10: Analysis of Oxidative Stress in Light of miRNA inhibition. a. Untreated hESC-RPEs. b. RPE cells treated 
with 320 µM of paraquat for 5 days. c. RPE cells expressing miR27b decoy treated with 320 µM of paraquat for 5 
days. d. RPE cells expressing miR29b decoy treated with 320 µM of paraquat for 5 days. e. and f. miR27b and 
miR29b decoy RPEs (respectively) expressing GFP under fluorescent microscopy. g. Quantitative real-time PCR 
analysis of NRF2/KEAP1 pathway products expressed by mir27b and miR29b decoy-expressing RPEs after 5-day 
treatment with 320 µM of paraquat. h. Quantitative real-time PCR analysis of pathology-associated miRNAs 
expressed by miR27b and miR29b decoy-expressing RPEs after 5-day treatment with 320 µM of paraquat.  
 
    Based on the data described above, we next sought to directly assess the effects of the 
manipulation of miRNA expression on the induction of an oxidative stress phenotype and RPE 
survival. With regards to inhibiting miRNA expression, we specifically focused on two miRNAs, 
miR27b and miR29b using a lentivirus-mediated expression method to express miRNA decoy 
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constructs. As seen in Figure 10a-10f, despite robust expression of miR27b and miR29b decoys, 
there is no clear increase in RPE death over the course of a 5-day treatment with 320 µM of 
paraquat. Although a mild disruption of the uniform, cobblestone-like morphology could be 
seen with paraquat treatment, the expression of the miRNA decoys didn’t induce any 
morphology significantly different from that induced by paraquat treatment alone. Interestingly 
however, quantitative real-time PCR analysis showed an upregulation of HMOX1 by up to a 2-
fold difference in RPEs expressing a miRNA decoy compared to unaffected RPEs treated with 
paraquat, as seen in Figure 10g. Even more intriguingly, it seems that the inhibition of miR29b 
and miR27b expression caused the inhibition of various other miRNAs such as miR205, miR28, 
miR146, miR200a, miR27a, and miR29a. This suggests either a global inhibition of the miRNA 
biogenesis pathway or potentially a cross-talk between the various oxidative stress response 
miRNAs and antioxidant response element genes. The decoys, through the activation of a 
negative regulator of other miRNAs, may have resulted in the inhibition of stress-associated 
miRNAs. Additionally, this suggests the striking upregulation of various other factors that may 
affect cell viability and functionality through the inhibition of miR27b or miR29b by miRNA 
decoy activity. 
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Figure 11: Analysis of Oxidative Stress in Light of miR144 Overexpression. a. Quantitative real-time PCR analysis 
of antioxidant response element expression after 1 week of treatment with 320 µM paraquat (PQ320) under 
conditions with elevated expression of miR144, compared to treated hESC-RPEs expressing a non-silencing 
scrambled miRNA construct. b. miRNA analysis of the samples described in a.  
 
    Because of the marked decrease in miR144 expression in high stress conditions, we also 
sought to asses the effects of miR144 overexpression on the oxidative stress response 
implemented by RPEs in high stress conditions.  To address this question, we induced the 
elevated expression of miR144 as well as a scrambled, non-silencing miRNA construct in a 
separate culture, both via lentivirus-mediated expression in hESC-RPEs.  As seen in Figure 11a, 
when compared to hESC-RPEs expressing a non-silencing miRNA construct, cells expressing 
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heightened levels of miR144 displayed slightly elevated expression of antioxidant response 
elements when treated with 320 µM paraquat for 1 week, particularly of HMOX1 and NQO1 by 
approximately a 0.5-fold change. However, with regards to miRNA expression, the elevated 
expression of miR144 with a similar stress treatment has been seen to induce the elevation of 
miR27a and miR29a, which further points to the hypothesis that the expression of miRNAs 
involved in a similar cellular function are affected by a change in the expression of one of the 
miRNAs involved. In this case, a pro-survival change in miRNA expression induced the elevated 
expression of miRNA27a and miRNA29a both of which have been shown to play a role in stress 
conditions. 
 
Conclusion 
    The etiology of AMD is one with an exceptionally complex nature. It is one that researchers 
find difficult to define due to a lack of a good model system when the limitations presented by 
immortalized cell lines and animal models are taken into consideration. In this study, we have 
generated an in vitro disease model using human embryonic stem cell-derived RPE cells that we 
believe reflects the nature of age-related macular degeneration using a protocol that allows us 
to observe the oxidative stress phenotype using time-dependent increases in stressor 
concentration. Using this model, we have been able to observe changes in miRNA expression of 
miRNAs such as miR144, miR29b1, miR29a, miR27b, and miR23a, which have previously been 
implicated in cancerous conditions. Additionally, these microRNAs exhibit changes in expression 
between low, short-term stress and high chronic stress, suggesting miRNA-based mechanisms 
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for immediate and long-term stress response for the purpose of maintaining cellular 
homeostasis, as outlined in the heatmaps presented in Figure 12. 
 
Figure 12: Differential Expression Between Low, Short-Term Stress (HQ100 and PQ40) and High, Chronic Stress 
(HQ400 and PQ160) with the Use of Paraquat and Hydroquinone.  
      
    We have also been able to correlate these findings with enhanced expression of products 
found in the NRF2/KEAP1 pathway. Interestingly, previously published publications indicate the 
anti-cancer role of NRF2/KEAP1 activity through cytoprotection against oxidant damage.[50] 
This, when taken into account the heightened expression of miRNAs such as miR29a and 
miR29b1, which have been speculated to have DNA-demethylating and anti-tumor 
capacities[48, 50], may indicate an anti-proliferative, antioxidant-associated mechanism used as 
a defense against cell death. However, further studies involving the expression of gene 
transcripts associated with cancer will have to be performed in order to further elucidate a 
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causal mechanism of action for such miRNAs which may play a role in pro-survival conditions in 
light of oxidative stress.  
    Of additional note, we have been able to make a preliminary observation of the effects of 
stress-related miRNA inhibition by the inhibition of miR27b and miR29b through the use of a 
decoy construct. We have also been able to note the effects of elevated stress-associated 
miRNA expression through the overexpression of miR144, which led to the increase in the 
expression of miR27a and miR29a, additional miRNAs implicated in RPE stress response. These 
observations suggest a mechanism of inter-miRNA communication as seen in current 
research,[50] where the inhibition of one miRNA affects the expression of various other related 
miRNAs which may play a role in biological mechanisms such as redox homeostasis. Further 
investigation will have to be performed in order to determine the role of factors that promote 
the repression of such miRNAs and then elucidate a mechanism portraying a regulatory 
network of stress-related miRNAs. However, such observations noted in this study suggest a 
promising potential in the role of miRNAs with regards to regulatory mechanisms that govern 
the response of RPE cells to chronic oxidative stress. This provides a new level of insight as well 
as potential target molecules of interest in studies involving the progression of AMD. 
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